IPXL Insider Trading
IPXL | Market Equity
Comprehensive Trading Performance Summary
The investment history of corporate insiders at IPXL provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2011-09-07 00:33 | 2011-09-01 | FLEMING NIGEL | Director | SELL | $19.04 | 14,640 | $278,746 | 10,666 | -57.9% |
| 2011-08-16 22:19 | 2011-08-16 | HSU LARRY | Director, Officer - President and CEO | BUY | $19.00 | 10,000 | $190,000 | 426,903 | +2.4% |
| 2011-08-08 23:49 | 2011-08-08 | BENET LESLIE Z | Director | BUY | $15.71 | 500 | $7,855 | 4,500 | +12.5% |
| 2011-08-06 00:53 | 2011-08-05 | BENET LESLIE Z | Director | BUY | $17.25 | 1,000 | $17,250 | 4,000 | +33.3% |
| 2011-06-10 00:21 | 2011-06-07 | MARKBREITER MICHAEL | Director | OPT+S | $23.26 | 20,334 | $472,949 | 10,666 | 0.0% |
| 2011-06-10 00:11 | 2011-06-07 | FLEMING NIGEL | Director | OPT+S | $23.45 | 13,334 | $312,682 | 25,306 | 0.0% |
| 2011-06-10 00:07 | 2011-06-07 | TERRERI PETER R | Director | SELL | $23.21 | 2,800 | $64,988 | 22,767 | -11.0% |
| 2010-12-14 04:33 | 2010-12-09 | FLEMING NIGEL | Director | OPT+S | $18.70 | 8,500 | $158,950 | 26,640 | 0.0% |
| 2010-12-03 22:34 | 2010-12-01 | BENET LESLIE Z | Director | OPT+S | $18.10 | 10,000 | $181,000 | 7,000 | 0.0% |
| 2010-11-09 17:22 | 2010-11-05 | Mengler Christopher | Other | SELL | $19.32 | 7,460 | $144,127 | 0 | -100.0% |
| 2010-11-03 17:24 | 2010-10-22 | Mengler Christopher | Other | SELL | $21.24 | 42,956 | $912,424 | 7,460 | -85.2% |
| 2010-08-20 20:02 | 2010-08-12 | CHAO ALLEN | Director | BUY | $15.72 | 13,800 | $216,936 | 180,000 | +8.3% |
| 2010-08-17 21:37 | 2010-08-13 | NESTOR MICHAEL | Officer - President, Impax Pharm. Div. | BUY | $16.06 | 1,645 | $26,419 | 3,645 | +82.3% |
| 2010-08-17 21:31 | 2010-08-13 | CHAO ALLEN | Director | BUY | $16.03 | 46,200 | $740,586 | 20,000 | +100.0% |
| 2010-08-12 23:01 | 2010-08-12 | Mengler Christopher | Officer - President, Global Pharm. Div. | BUY | $15.19 | 2,000 | $30,380 | 59,706 | +3.5% |
| 2010-08-12 22:02 | 2010-08-12 | HSU LARRY | Director, Officer - President and CEO | BUY | $15.40 | 5,000 | $77,000 | 2,369,568 | +0.2% |
| 2010-08-12 21:31 | 2010-08-11 | HSU LARRY | Director, Officer - President and CEO | BUY | $16.03 | 10,000 | $160,300 | 2,364,568 | +0.4% |
| 2010-08-12 21:28 | 2010-08-10 | FLEMING NIGEL | Director | OPT+S | $16.83 | 7,500 | $126,225 | 26,640 | 0.0% |
| 2010-06-08 23:15 | 2010-06-04 | TERRERI PETER R | Director | SELL | $20.51 | 1,465 | $30,047 | 14,535 | -9.2% |
| 2010-06-08 23:15 | 2010-06-04 | FLEMING NIGEL | Director | SELL | $20.37 | 1,360 | $27,703 | 26,640 | -4.9% |
| 2010-06-08 23:13 | 2010-06-04 | BURR ROBERT L | Director | SELL | $20.32 | 1,000 | $20,320 | 44,150 | -2.2% |
| 2010-05-25 01:11 | 2010-05-20 | MARKBREITER MICHAEL | Director | OPT+S | $19.86 | 19,000 | $377,251 | 8,000 | 0.0% |
| 2010-05-19 17:21 | 2010-05-17 | FLEMING NIGEL | Director | OPT+S | $19.50 | 8,000 | $156,000 | 24,000 | 0.0% |
| 2010-05-11 03:20 | 2010-05-07 | BENET LESLIE Z | Director | OPT+S | $17.10 | 12,000 | $205,189 | 3,000 | 0.0% |
| 2010-03-04 22:57 | 2010-03-02 | MARKBREITER MICHAEL | Director | OPT+S | $15.38 | 15,000 | $230,700 | 12,000 | 0.0% |
| 2009-11-10 00:52 | 2009-11-06 | MARKBREITER MICHAEL | Director | OPT+S | $9.70 | 4,000 | $38,800 | 12,000 | 0.0% |
| 2009-08-18 18:24 | 2009-08-14 | FLEMING NIGEL | Director | OPT+S | $7.69 | 4,000 | $30,770 | 24,000 | 0.0% |
| 2009-05-12 23:13 | 2009-05-08 | Mengler Christopher | Officer - President, Global Pharm. Div. | BUY | $5.85 | 1,000 | $5,850 | 47,000 | +2.2% |
| 2009-03-26 00:38 | 2009-03-25 | Mengler Christopher | Officer - President, Global Pharm. Div. | BUY | $5.50 | 1,000 | $5,500 | 46,000 | +2.2% |
| 2009-03-17 16:46 | 2009-03-13 | NESTOR MICHAEL | Officer - President, Impax Pharm. Div. | BUY | $5.59 | 2,000 | $11,180 | 2,000 | +100.0% |
| 2009-03-16 20:50 | 2009-03-13 | Hildenbrand Charles V | Officer - SVP, Operations | BUY | $5.75 | 5,000 | $28,750 | 5,000 | +100.0% |
| 2009-01-26 20:42 | 2009-01-23 | HSU LARRY | Director, Officer - President and CEO | BUY | $3.80 | 12,900 | $49,020 | 2,483,771 | +0.5% |
| 2009-01-24 02:02 | 2009-01-22 | KOCH ARTHUR A JR | Officer - SVP, Finance, and CFO | BUY | $3.99 | 5,000 | $19,938 | 5,000 | +100.0% |
| 2009-01-24 01:59 | 2009-01-22 | HSU LARRY | Director, Officer - President and CEO | BUY | $3.98 | 87,100 | $346,353 | 2,470,871 | +3.7% |
| 2005-03-04 17:56 | 2005-03-02 | CHU MAY | Officer - Sr. VP Quality Affairs | BUY | $14.36 | 139 | $1,996 | 55,427 | +0.3% |
| 2005-03-04 17:19 | 2005-03-02 | HSU LARRY | Director, Officer - President | BUY | $14.36 | 139 | $1,996 | 2,383,910 | +0.0% |
| 2005-03-04 00:53 | 2005-03-02 | HSIAO CHARLES | Director | BUY | $14.36 | 139 | $1,996 | 3,610 | +4.0% |
| 2004-12-09 01:33 | 2004-12-02 | HSIAO CHARLES | Director | BUY | $10.94 | 183 | $2,002 | 3,471 | +5.6% |
| 2004-12-06 23:52 | 2004-12-02 | CHU MAY | Officer - Senior VP - Quality Affairs | BUY | $10.94 | 183 | $2,002 | 55,288 | +0.3% |
| 2004-12-03 23:29 | 2004-12-02 | HSU LARRY | Director, Officer - President | BUY | $10.94 | 183 | $2,002 | 2,383,771 | +0.0% |
| 2004-12-03 23:05 | 2004-12-02 | HSIAO CHARLES | Director | BUY | $0.00 | 3,531,788 | $2,119 | 3,531,605 | +100.0% |
| 2004-11-29 23:04 | 2004-11-24 | HSU LARRY | Director, Officer - President | BUY | $0.75 | 333,580 | $250,185 | 2,383,855 | +16.3% |
| 2004-09-10 18:06 | 2004-09-09 | CHU MAY | Officer - Senior VP - Quality Affairs | SELL | $16.80 | 6,258 | $105,134 | 55,105 | -10.2% |
| 2004-09-02 22:48 | 2004-09-01 | HSIAO CHARLES | Director | BUY | $12.58 | 159 | $2,000 | 3,288 | +5.1% |
| 2004-09-02 21:55 | 2004-09-01 | CHU MAY | Officer - Senior VP Quality Affairs | BUY | $12.58 | 159 | $2,000 | 61,363 | +0.3% |
| 2004-09-02 20:52 | 2004-09-01 | HSU LARRY | Director, Officer - President | BUY | $12.58 | 159 | $2,000 | 2,050,275 | +0.0% |
| 2004-06-18 16:15 | 2004-06-07 | MARKBREITER MICHAEL | Director | SELL | $21.89 | 20,000 | $437,772 | 0 | -100.0% |
| 2004-06-18 16:15 | 2004-06-07 | MARKBREITER MICHAEL | Director | BUY | $2.59 | 20,000 | $51,876 | 20,000 | +100.0% |
| 2004-06-18 15:21 | 2004-06-07 | SPIEGLER CORNEL C | Officer - Chief Financial Officer | SELL | $21.82 | 56,000 | $1,221,853 | 10,750 | -83.9% |
| 2004-06-18 15:21 | 2004-06-07 | SPIEGLER CORNEL C | Officer - Chief Financial Officer | BUY | $3.03 | 56,000 | $169,747 | 66,750 | +520.9% |
How to Interpret $IPXL Trades
Not every insider transaction in IPXL is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $IPXL shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for IPXL
Insider activity data for IPXL is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $IPXL, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.